Andreas Wicki, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 155,706 shares at $61.23 ($9.5M) on 2022-12-05, disclosed to the SEC on 2022-12-07.
Open-market sale of $9.5M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.23 | 77,853 | $4.8M | 50.0% |
| 2 | $61.23 | 77,853 | $4.8M | 50.0% |
| Total | $61.23 avg | 155,706 | $9.5M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |
| HRMY | SELL | 2022-08-10 | $62.2M | — | Filing → |